C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
10/2002
10/24/2002	US20020156114 Antiinflammatory, antiarthritic agents
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444267A1 Prodrugs of cox-2 inhibitors
10/24/2002	CA2444220A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine
10/24/2002	CA2444148A1 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	CA2440842A1 Novel 1h-indazole compounds
10/23/2002	EP1251126A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
10/23/2002	EP1250326A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
10/23/2002	CN1376155A Thiourea and isothiourea derivatives for inhibiting RAS-transformed cell growth
10/23/2002	CN1376147A 吡唑类衍生物 Pyrazole derivatives
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376031A 除草组合物 Herbicidal compositions
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469041 Certain pyrazole derivatives as corticotropin-releasing factor CRF1 ligands
10/22/2002	CA2227264C Amine acid salt compounds and process for the production thereof
10/17/2002	WO2002081452A1 Charge-transfer substance and process for producing the same, electron-transfer agent comprising charge-transfer substance, electrophotographic photoreceptor, and organic electroluminescent element
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002081429A1 Novel compound having oxime group and insecticide/acaricide
10/17/2002	WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002	WO2002080927A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002	WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/17/2002	WO2002080909A1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
10/17/2002	WO2002080908A1 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002	US20020151570 Thiosulfonic acid S-esters as agents for protecting material
10/17/2002	DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/17/2002	CA2443031A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002	CA2443015A1 Aryl (or heteroaryl) azolylcarbinole derivatives for the treatment of respiratory diseases
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248781A1 Pyrazole cyclic amp-specific pde inhibitors
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374306A Prepn of improved pesticide intermediate
10/16/2002	CN1374298A Sulfenylation process of pyrozole compound with trifluoromethanesulfonyl radical
10/15/2002	US6465658 Reacting azolide salts with phosgene in an aromatic compound or an ether as solvent
10/15/2002	US6465656 Acylating/acetylating arylhydrazine, reacting hydrozonoyl halide/sulfate with amine base to form 1-(3-cyano)phenyl-2-(trifluoroacetyl)hydrazine
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002	WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002066440A8 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
10/10/2002	WO2002057215A3 Sodium channel modulators
10/10/2002	WO2002006512A3 Method for detecting uracil biosynthesis inhibitors and their use as herbicides
10/10/2002	US20020147336 Glucocorticoid receptor modulators
10/10/2002	DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002	CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002	CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002	EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP1000025A4 Substituted naphthopyrans
10/09/2002	EP0971714B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/09/2002	EP0830342B1 Azolyl oxybenzyl alkoxyacrylic acid esters, process for producing them and their use
10/09/2002	CN1373754A Antibacterial agents
10/09/2002	CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002	CN1092186C Method for preparing 1,2-dimethyl-3,5-diarylpyrazolium methyl sulfates
10/08/2002	US6462199 Photographic additive
10/08/2002	US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002	US6462069 Kinase inhibitors; anticancer agents
10/08/2002	US6462049 Low toxicity and persistent insecticides and fungicides; preventing attachment of aquatic organisms; ecosystem friendly; nonpolluting
10/08/2002	US6462039 Fungicidal benzoheterocyclyloxime
10/08/2002	US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002	CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/03/2002	WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002	WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002	WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	WO2002076918A1 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
10/03/2002	WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002	US20020143036 Pentafluorobenzenesulfonamides and analogs
10/03/2002	US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002	CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002	CA2410816A1 Nf-.kappa.b inhibitor containing substituted benzoic acid derivative as active ingredient
10/02/2002	EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002	EP1244633A1 Pyrazolyl benzyl ether derivatives containing a fluoromethoxyimino group and use thereof as pesticides
10/02/2002	EP1244632A1 Pyrazole derivatives which modulate human serotonin receptors
10/02/2002	DE10111862A1 Neue Diaminopyrazol-Derivate und diese Verbindungen enthaltende Färbemittel New diaminopyrazole derivatives and compounds containing colorants
10/02/2002	CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002	CN1091765C Novel 5-amino-2-cyano-4-ethylsulfinyl-1-phenyl-pyrazole compounds and their use as pesticides
10/02/2002	CN1091764C Pesticidal sulfur compounds
10/01/2002	US6458960 Sulfonamide derivatives
10/01/2002	US6458844 Antiinflammatory agents
10/01/2002	US6458823 4,5-diamino derivatives of (1h)- pyrazoles and their use in the treatment of disorders associated with smooth muscle contraction, which include, urinary incontinence, hypertension, asthama, premature labor, irritable bowl syndrom
10/01/2002	US6458781 Blockers calcium channel antagonists for strokes, brain disorders
10/01/2002	US6458744 A 4-thiomethylpyrazole
09/2002
09/26/2002	WO2002074740A1 Biguanide derivatives
09/26/2002	WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/26/2002	WO2002074235A2 Heterocyclic compounds for therapeutic use
09/26/2002	WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002	WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002	WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor

1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 256